Return to homepagePandemic Pact

Midwest Biomedical Accelerator Consortium: MBArC

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3U01HL152410-02S2

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020.0
    2023.0

  • Known Financial Commitments (USD)

    $351,108

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    DIRECTOR William Fay

  • Research Location

    United States of America

  • Lead Research Institution

    UNIVERSITY OF MISSOURI-COLUMBIA

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system, termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The proposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that will fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.